Stabicon specialized in managing product quality process, upgrading and introducing advanced technology into products. We are proud to lay a foundation for prosperous future in prevention and cure segment, future medicine & FMCG business. Established in September 2010. Team experience spans across from design to concept, lab to commercialization of product and with competent technical experts. Automated Process driven and prepared for integration with partner site for transparency and real time access on each application.

1. Corporate Presentation

2. Contoso Ltd.
2
Stability
Center
2010
2012
2013
2014
2015
2016
2017
2018
2019
Health
Canada
Approval
WHO(Geneva),
ISO –
17025,Product
Certification
Center
Bio Wavier
Division
Formulation
Development
Center
Platform
Technology
Center
Metabolism
& Infection
(AMR)
Commerciali
zation of
Technology
Clinical
Supply
History
www.stabicon.com
Started Operation

3. Contoso Ltd.
3
www.stabicon.com
Division
43
21 STRATEGIC PARTNERING
Market Expansion, Product line
expansion, Technical Expertise &
Co Development
TRANSACTIONAL
TECHNOLOGY
Niche dosage (Nasal, Topical & Oral),
Preservative Free, Nano Form,
Therapeutic Area, Wellness, Pain
Management, Hygiene products and
complex product dosage category
MANUFACTURING
Specialized Product Manufacturing
Stability, Formulation, Analytical
Research, Invitro Studies and
Integrated services

4. Contoso Ltd.
4
• Specialized in managing product quality process, upgrading
and introducing advanced technology into products. we are
proud to lay a foundation for prosperous future in
prevention and cure segment, future medicine & FMCG
business.
• Established in September 2010.
• Team experience spans across from design to concept, lab to
commercialization of product and with competent technical
experts.
• Automated Process driven and prepared for integration with
partner site for transparency and real time access on each
application.
Overview
www.stabicon.com

5. Contoso Ltd.
Audited and approved by WHO,
Geneva01
Accredited by ISO / IEC
17025:2005 (NABL)
Approved by Health Canada
Registered with DSIR
2
1
3
4
5
6
02
03
04
05
06
Approved by FDA (India)
Registered with US FDA
5
Regulatory Compliance
www.stabicon.com

6. Contoso Ltd.
6
• Professional Management with a strength of
100+ scientists.
• Strong management governance
• Lean Organization - quicker decision
• Integration functional area expertise under
one umbrella
• Easy to scale up or modify as most of process
are automated
• State of art infrastructure
• Compliant with EHS regulations
Infrastructure
www.stabicon.com

7. Contoso Ltd.
7
Unmet needs- Therapeutic Solution
www.stabicon.com
 Non – Conventional Approach
 Reduce Development window
& Dosage
Optimization

8. Contoso Ltd.
Value Creation
Strengthening
manufacturing excellence &
process transformation
initiatives
Automation Initiatives
in the value chain
Facilitating Development of
An Innovation Portfolio
Designing of World Class
Facilities and Developing
Robust Infrastructure
Dedicated Center - Project
8www.stabicon.com

9. Contoso Ltd.
9
Platform Technology
www.stabicon.com
• Effective Delivery Designing Model concept to
reduce toxicity, & improve delivery
• Lymphatic Transport System Delivery – by pass
first phase metabolism.
• Preservative Free
• Improving Solubility & Bioavailability for Class II
& IV category technology.
• Control Release using trigger such as time, pH
,temp & moisture to deliver actives more specific
profiles, such as pulsatile and delayed release
• Improving delivery of sensory, taste & colour
substance.

10. Contoso Ltd.
10
Consumer /OTC - Products
www.stabicon.com
 Change Management
 Technology Migration
 Quality Assessment and
Review
 Troubleshooting/Defect
Analysis
 Pre – study
 Concept Design and Ideation
 Detailed Design and Analysis
 Final Design
 After Sales
 Performance Improvement
 Benchmarking
 Manufacturing Process Optimization
 Value Engineering
 Knowledge Based Engineering
 Design Automation
 Data and Model Recognition from Documents
Product Lifecycle
Product Sustenance
Growth Solution
Automation

11. Contoso Ltd.
11
Prescription (Rx)– Products
www.stabicon.com
Combinations
 Improve
Activity
Formulation
or dosage form
Route of
Administration
 Oral,
Transdermal ,
Inhalation or
Injectable
Complex Active
Ingredients
Complex
Formulation
Complex Root of
Delivery
Complex Drug-
Device
Combination
Prototype Validation Study Clinical Study
Regulatory –
Dossier
Submission

12. Contoso Ltd.
12
Formulation & Development Bio waiver AMR - HTS
Microbial Studies
Platform Technology
Product & Device
Certification
Centralized Stability
Clinical Supply Referral lab & Turn KeyBrand
Services Suite
www.stabicon.com

13. Contoso Ltd.
13
Business Solution
www.stabicon.com

14. Contoso Ltd.
Canada
Europe
United States
Asia
Africa
14
Our Client base
www.stabicon.com

15. Thank You
Business Development
+91 80 41250324
bd@stabicon.com, info@stabicon.com
www.Stabicon.com
© 2020, Stabicon Life Sciences Pvt. Ltd. All Rights Reserved.